The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop
Open Access
- 9 September 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in The European Journal of Health Economics
- Vol. 14 (5), 789-797
- https://doi.org/10.1007/s10198-012-0424-5
Abstract
The txt2stop trial has shown that mobile-phone-based smoking cessation support doubles biochemically validated quitting at 6 months. This study examines the cost-effectiveness of smoking cessation support delivered by mobile phone text messaging. The lifetime incremental costs and benefits of adding text-based support to current practice are estimated from a UK NHS perspective using a Markov model. The cost-effectiveness was measured in terms of cost per quitter, cost per life year gained and cost per QALY gained. As in previous studies, smokers are assumed to face a higher risk of experiencing the following five diseases: lung cancer, stroke, myocardial infarction, chronic obstructive pulmonary disease, and coronary heart disease (i.e. the main fatal or disabling, but by no means the only, adverse effects of prolonged smoking). The treatment costs and health state values associated with these diseases were identified from the literature. The analysis was based on the age and gender distribution observed in the txt2stop trial. Effectiveness and cost parameters were varied in deterministic sensitivity analyses, and a probabilistic sensitivity analysis was also performed. The cost of text-based support per 1,000 enrolled smokers is £16,120, which, given an estimated 58 additional quitters at 6 months, equates to £278 per quitter. However, when the future NHS costs saved (as a result of reduced smoking) are included, text-based support would be cost saving. It is estimated that 18 LYs are gained per 1,000 smokers (0.3 LYs per quitter) receiving text-based support, and 29 QALYs are gained (0.5 QALYs per quitter). The deterministic sensitivity analysis indicated that changes in individual model parameters did not alter the conclusion that this is a cost-effective intervention. Similarly, the probabilistic sensitivity analysis indicated a >90 % chance that the intervention will be cost saving. This study shows that under a wide variety of conditions, personalised smoking cessation advice and support by mobile phone message is both beneficial for health and cost saving to a health system.Keywords
This publication has 21 references indexed in Scilit:
- Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trialThe Lancet, 2011
- Txt2stop: a pilot randomised controlled trial of mobile phone-based smoking cessation supportTobacco Control, 2009
- Lifetime Medical Costs of Obesity: Prevention No Cure for Increasing Health ExpenditurePLoS Medicine, 2008
- Does Quality of Life of COPD Patients as Measured by the Generic EuroQol Five-Dimension Questionnaire Differentiate Between COPD Severity Stages?Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2006
- Nicotine replacement therapy for long-term smoking cessation: a meta-analysisTobacco Control, 2006
- Do u smoke after txt? Results of a randomised trial of smoking cessation using mobile phone text messagingTobacco Control, 2005
- Cost-Effectiveness of Face-to-Face Smoking Cessation Interventions: A Dynamic Modeling StudyValue in Health, 2005
- Abstinence from smoking eight years after participation in randomised controlled trial of nicotine patchBMJ, 2003
- Cigarette Smoking and Self-Reported Health Problems among U.S. High School Seniors, 1982–1989American Journal of Health Promotion, 1995
- Mortality in relation to smoking: 40 years' observations on male British doctorsBMJ, 1994